Evaluating the Impact of Cerebral Ischemic And Degenerative Changes On Cognition

Molecular Cerebral Imaging in Incipient Dementia (MCI-ID) II

NCT02317250 ·Status: WITHDRAWN ·Phase: PHASE3

Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease

NCT00249080 ·Status: COMPLETED

Developing a New EEG Method for the Early Diagnosis of Dementia

NCT02426398 ·Status: RECRUITING

The Relevance of the Blood-brain Barrier to Cognitive Dysfunction and Alzheimer's Disease

NCT04093882 ·Status: COMPLETED

Magnetic Resonance Imaging for the Study of Patients With Neurological Disorders

NCT00001362 ·Status: COMPLETED

Assess Fibrin in Brains With AD/ADRD

NCT05336695 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

PET Imaging of Cyclooxygenases in Neurodegenerative Brain Disease

NCT04396873 ·Status: RECRUITING ·Phase: PHASE1

A Phase 3 Clinical Trial to Evaluate the Efficacy and Safety of [18F]NAV4694 PET for Detection of Cerebral Beta-Amyloid When Compared With Postmortem Histopathology

NCT01886820 ·Status: UNKNOWN ·Phase: PHASE3

Early Diagnosis of Alzheimer's Disease: Clinical, Neuropsychological and Neuroimaging Follow-up of a Cohort of Patients With an Isolated Memory Impairment

NCT00684281 ·Status: COMPLETED ·Phase: NA

A Composite MR Neuroimaging Marker for Alzheimer's Disease

NCT01615666 ·Status: WITHDRAWN

Use of [123I] AV39 and SPECT Imaging as a Marker of Protein Disposition in Subjects With Alzheimer Disease Compared to Healthy Subjects

NCT00439010 ·Status: COMPLETED ·Phase: PHASE1

Automated Brain Morphometry for Dementia Diagnosis

NCT02286505 ·Status: UNKNOWN ·Phase: NA

Study of Phosphorylated Metabolism Profile as Predictive Biomarker of Cognitive Decline in Memory Complaint.

NCT03863041 ·Status: COMPLETED ·Phase: NA

Multimodal Imaging in the Study of Disorientation in the Hospital

NCT04387357 ·Status: UNKNOWN

[18F]AV45(Aβ) and [18F]AV1451(Tau)PET/CT in the Diagnosis of Early Pathological Changes of Alzheimer's Disease

NCT06833645 ·Status: RECRUITING

Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias

NCT04786223 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2

Magnetic Resonance Imaging (MRI) of Tumor Response and Cognitive Impairment in Breast Cancer Patients Undergoing Chemotherapy

NCT01045044 ·Status: WITHDRAWN

Default Mode Network fMRI Maps as a Predictive Index of Hepatic Encephalopathy Outcome

NCT02083367 ·Status: COMPLETED

Longitudinal MRI Examinations of Patients With Brain Ischemia and Blood Brain Barrier Permeability

NCT02077582 ·Status: UNKNOWN

Molecular and Structural Imaging in Alzheimer's Disease: A Longitudinal Study

NCT02740634 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Intelligent Analysis and Clinical Validation of Cerebral Small Vessel Disease on Magnetic Resonance Imaging：A Multi-center Study

NCT06667635 ·Status: NOT_YET_RECRUITING

Determinants of Cognitive Impairment After Acute Coronary Syndrome

NCT00982176 ·Status: COMPLETED

Using Neuroimaging to Early Diagnose Alzheimer's Disease Through Hippocampal Atrophy Assessment

NCT06965816 ·Status: COMPLETED

Early Detection of Mild Cognitive Impairment in Individual Patients

NCT00243451 ·Status: COMPLETED

Longitudinal Evaluation of Familial Frontotemporal Dementia Subjects

NCT02372773 ·Status: COMPLETED